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Abstract: Pseudouridine (< is an important urinary cancer biomarker, especially in human 
colorectal cancer (CRC). Disclosed herein is the first pseudouridine molecularly imprinted 
polymer (<-MIP) material obtained from tailor-engineered functional monomers. The 
resulting MIP imprint exhibits a remarkable imprinting factor greater than 70. It is 
successfully used for the selective recognition of pseudouridine in spiked human urine. This 
selective functionalized material opens the route to the development of inexpensive 




Pseudouridine (5-ȕ-D-ribofuranosyluracil) (<) is a C-glycoside type of naturally modified 
nucleoside, found in rRNA and tRNA of bacterial and mammalian origin.[1] In the growth of 
cancer cells or some viral disease, due to the high turnover of tRNA, concentrations of 
pseudouridine have been released in biofluids, allowing to begin a highly relevant molecule 
for monitoring of cancer growth.[2] Since < does not undergo regular metabolic degradation 
processes because of the lack of the enzyme that can metabolize C-glycoside nucleosides,[3] it 
found in the human urine. The difficulty is to select an appropriate method to monitor 
selectively this biomarker among several dozens of nucleoside analogues [4]. The common 
techniques for its detection, enzyme-linked immunosorbent assay (ELISA),[5] micellar 
electrokinetic capillary chromatography (MECC),[6] matrix assisted laser desorption 
ionization-time of flight mass spectrometry (MALDI-TOF MS)[7] require costly and time-
consuming equipment and often involve preliminary treatments with a risk to lose or modify 
the active compound. So, to meet this kind of challenge, recently, biosensors based on well-
known molecularly-imprinted polymers (MIP)[8-11] have gained of interest since they are 
compatible with different transducers and can recognize a molecule without pre-analytical 
preparations. However, the cornerstone of such polymer-based receptors remains the design 
of their material component, which defines their specificity and overall quality. For 
pseudouridine, a C-C glycosidic isomer of uridine (U), which shares with U similar physico-
chemical data, the conception of highly selective MIP is very challenging (Figure 1). The 
technique of molecular imprinting aims to replicate synthetically the phenomenon of 
molecular recognition occurring in biological systems, such as enzymes or antibodies.[12] It 
provides synthetic materials possessing selective cavities (size, shape and functionality) of a 
given molecule, called guest molecule or template molecule, here pseudouridine. According 
to the manner how the template is connected to the functional monomer and subsequently to 
the selective binding sites, the molecularly imprinted polymer (MIP) can show a such 
VHOHFWLYLW\ WKDW WKLV PDWHULDO LV VRPHWLPHV QDPHG ³SODVWLF DQWLERG\´.[13] To obtain this high 
molecular recognition ability, the monomer which functionalizes the material is the key point 
of the formulation. We have chosen to synthesize selective monomers able to interact with 
<through multiple hydrogen bonds, to form a 1:1 pre-polymerization complex, in order to 
enhance its adsorption on imprinted polymer in comparison to a non-imprinted one. This type 
of approach is known as stoichiometric non-covalent interactions imprinting, as described by 
Tanabe et al.[14] The major advantages of this non-covalent imprinting is to work without 
excess of small functional monomers, such as acrylamide, acrylic acid,... in order to move the 
equilibrium to the formation of the pre-polymerization complex[15] and to decrease non-
specific interactions. So, in this study, we developed the first pseudouridine-MIP obtained 
from tailor-engineered functional monomers, able to discriminate, with remarkable imprinting 




2. Results and Discussion 
 
2.1. Design of imprinted materials 
We used a stoichiometric non-covalent imprinting approach, in order to reduce the number of 
non-specific interactions present in the obtained MIPs and to show fast binding kinetics, 
contrary to classical non-covalent and covalent approaches, respectively.[16,17]  An aprotic 
porogenic solvent and a derivative of <were used to promote strong non-covalent 
associations, by hydrogen bonding interactions, between the nucleobase part of <and tested 
monomers, ensuring selectivity of recognition when close nucleoside analogues were present 
LQ WKH VDPSOH 7KXV WKH ¶¶¶-tri-O-acetyl pseudouridine (TAc<) was used as a dummy 
template instead of < to overcome the poor solubility of the latter in organic aprotic solvents, 
generally preferred for the imprinting process.[18]  A set of four monomers which differed in 
the number of theoretical recognition sites and thermodynamic preferences for the 




2.1.1. Choice of functional monomers 
Acrylamide (1) was chosen as a reference to classical non-covalent imprinting and should 
interact with the C(=O)NH groups present on pseudouridine, (Figure 3).[19,20] The 2,6-
bis(acrylamido)pyridine monomer 2 was already used in the stoichiometric imprinting of 
uracils.[21-23]  Monomer 3, inspired by the polymerizable version of a biotin-cleft,[24] allowed 
to evaluate selective interactions with the additional ±N(1)H of <. Monomer 4, inspired from 
barbiturate recognition,[25] was used to create more anchorage points than monomers 2 or 3 by 





2.1.2. Choice of polymerization solvent 
Solubility tests of the TAc< and monomers (1-4) were performed in a range of solvents 
(chloroform, acetonitrile, dimethyl sulfoxide and 1,4-dioxane/THF (3/1, v/v), differing in 
their isoelectric constants and hydrogen bonding capabilities. The testing was carried out 
separately by raising the mass of the templates or monomer in 1 mL of solvent and 
subsequently mixing until precipitation was observed. The wanted solubility limit for the 
polymers synthesis was 100 mM, (Table S1).  Chloroform was the solvent of choice for all 
formulations except those containing monomer 4, for which a binary ether type solvents 
mixture presenting the same Hansen Solubility Parameters was selected.[26] 
 
2.1.3. Stability of pre-polymerisation complexes 
The pre-polymerisation complexes between the functional monomers 1-4 and the TAc< was 
studied by NMR titrations on a 1:1 binding model to obtain the apparent binding constant 
(Kapp DQG WKH PD[LPXP LQGXFHG VKLIW ǻHG; the isothermal titration calorimetry (ITC), 
performed in chloroform, allowed calculating the Kb 1 ǻ+ DQG ǻ6 PHDQZKLOH WKH
interaction Gibbs free energies of complexes were calculated by molecular modelling. All 




By observing the association constant in 1H-NMR titration, we believe the strength of 
DVVRFLDWLRQ LQVLGHHDFKFRPSOH[FDQEHH[SODLQHGE\ WKHQXPEHURI WKHRUHWLFDOO\ ³SRVLWLYH´
K\GURJHQERQGLQJDQG³QHJDWLYH´LQWHUDFWLRQVVWHULFHIIHFWH[LVWLQJEHWZHHQWHPSODWHDQG
monomer (Figure 3).[27,28] 1H-NMR titration study confirmed the preference of monomer 3 
for a more stable interaction with the < nucleobase where a higher value of Kapp=352±49 M-1 
was obtained for complex TAc</3. Therefore, the complex stability established by NMR was 
TAc</3 > TAc</2 > TAc</4. 
To support this finding, for TAc</3 and TAc</2 complexes, a computational approach based 
RQ ')7 FDOFXODWLRQV RI PROHFXODU LQWHUDFWLRQV *LEEV IUHH HQHUJLHV ǻ* IRU WKH 
complexes in CHCl3, as well as in water (anticipating the behavior of the polymer in aqueous 
medium), confirmed the order of ligand stability as 3 > 2. Moreover, the ITC titration 
FRQILUPHG  VWRLFKLRPHWU\ DQG LQGLFDWHG E\ WKH QHJDWLYH ǻ* YDOXHV WKDW IRUPDWLRQ RI
complexes in chloroform was a spontaneous process. The process of complexation was 
exothermic and driven by hydrogen and van der Waals interactions.[29]  Moreover, the 
GLIIHUHQFH LQ ǻ+ PHDVXUHPHQWV EHWZHHQ FRPSOH[HV 7$F</2 and TAc</3 reflected the 
differences in the number of favourable interactions existing in each complex.[30] The negative 
entropy implicated in TAc</3 formation showed a reduction of degrees of freedom in the 
system showing better complexation than for complex TAc</2.[31]  
These complementary techniques showed that the best complexes and affinity of monomers 
toward TAc< are   3 > 2 > 4> 1. 
 
2.2. Optimized synthesis of imprinted polymers 
To explore the influence of those monomers on the polymer recognition behavior, four bulk 
polymers were prepared from template TAc<,  monomers 1-4, ethylene glycol dimethacrylate 
(EGDMA) as the cross-OLQNHU DQG WKH SRO\PHUL]DWLRQ LQLWLDWRU ¶-azobis(2,4-
dimethylvaleronitrile (ABDV). Along with the imprinted polymers (MIPs-1 to -4), the 




Obtained MIPs were packed in a stainless-steel HPLC columns in order to determine the 
selectivity factor (D), imprinting factor (IF), retention factor (k),  affinity and capacity of each 
polymer for thirteen nucleosides: the template (TAc<), the target compound (<), some 
pyrimidine nucleosides (6, 7, 8, 11) and seven purine purine nucleosides (9, 10, 12, 13, 14, 15, 
16) (Figure 4).  
 
[FIGURE 4] 
2.3. Imprinting efficiency evaluation by HPLC  
The retention based on polar non-covalent interactions was characterized in acetonitrile as 
mobile phase (Table S2, Figure S3), and the efficiency of recognition was evaluated in 
synthetic urine (Figure S4, Table S3). The use of monomers with various size, flexibility and 
interaction points produces polymers that exhibit different recognition behaviours.  
As expected, the acrylamide based MIP-1 gave poor retention behaviour compared to NIP in 
both organic and aqueous phase, meanwhile for MIP-4 a low specificity of this polymer was 
observed (correlated to the titration results). MIP-2 and MIP-3 showed stronger retention for 
the template, target and close pyrimidine analogues in organic and aqueous medium. Among 
all polymers, MIP-3 demonstrated high recognition for target < in synthetic urine, giving a 
very high IF value of 70 (Figure S4C), as predicted by the DFT results in water. In addition, 
the retention of other modified nucleosides was significantly lower, demonstrating the 
efficacy of tailored-made monomer 3 for selective recognition of <. This result is exceptional 
compared to similar previously published studies for the recognition of nucleosides in an 
aqueous phase.[32]  
 
2.4. Evaluation of the affinity constant and adsorption capacity of polymers 
The affinity constant and number of usable binding sites per unit polymer mass were 
determined for each polymer by frontal chromatography. The tested models used calculations 
based on isothermal (25°C) equilibrium adsorption thermodynamics. From each concentration 
step, the corresponding amount of the bound analyte (Q) was calculated and plotted against 
the corresponding template concentration (Cf) in the organic mobile phase. The experimental 
results (Figure 5) demonstrated that MIP-3 has a much higher capacity than other polymers 
based on the largest difference between the level of adsorption isotherms compared to NIP-3, 
and the fact that MIPs-1, 2 and 4 reached a saturation point at a lower level than MIP-3. 
Further, in the low concentration range (Figure 5, insert), MIP-2 and MIP-3 showed some 
significant adsorption and possible presence of theoretically high energy binding sites with a 
mean affinity constant of Ka >106 M-1, and with very low non-specific adsorption on the 
corresponding NIPs. This confirms that MIP-3 has a high recognition capacity for target <.   
[FIGURE 5] 
Concerning the modeling of adsorption isotherms (Table S5), MIP-2 and MIP-3 were fitted 
better to a bi-Langmuir model, describing a more homogeneous surface with theoretically 
only two types of binding sites (high and low affinity). However, MIP-2 did not show a great 
difference in affinity between the low and high affinity sites. Furthermore, looking at the 
overall number of both types of binding sites, MIP-3 had a higher number of binding sites, 
ZLWK WKH KLJKHVW DIILQLWLHV DPRQJ DOO WKH SRO\PHUV ZLWK  ȝPROJ-1 of high affinity 
(Ka=9.5x103 L.mol-1YVȝPROJ-1 of low affinity (Ka=0.63x103 L.mol-1) binding sites. This 
result is in agreement with the high performance liquid chromatography (HPLC) retention 
data discussed previously. MIP-4 was the only polymer that showed the best fit to the 
Langmuir-Freundlich model, describing both saturation and sub-saturation areas, giving a 
total nuPEHU RI ELQGLQJ VLWHV RI  ȝPROJ-1 with an affinity of Ka=0.64x103 L.mol-1 and 
confirming that MIP-4 has at least some binding capability, as demonstrated in the HPLC 
study; however, it has a low specificity as demonstrated by the small difference between MIP 
and NIP adsorption capacity levels (Figure 5). For NIP-1, -2, and -4, adsorption of template 
fitted a Langmuir-Freundlich model, and for NIP-3 to the Freundlich model. From the results 





2.4. Selective extraction of pseudouridine from synthetic urine 
MIP-3 was the best candidate for selective recognition of < in real human biological sample 
and it was used as a molecularly imprinted solid phase extraction (MISPE) sorbent. At first, 
synthetic urine was used in order to mimic the real sample and to observe the influence of the 
complex matrix on polymer recognition capabilities.[34]  The cross-rebinding studies were 
performed using a mixture of < and its close analogues 5, 6 and 7 (Figure 4), which can be 
found in the urine of colorectal cancer (CRC) patients. 5-Fluorouracil (5), which lacks the 
same chemical functionalities to interact with the polymer[35] was included since it is a 
pyrimidine analogue frequently used as a cytostatic in cancer treatment.  
With the optimized extraction protocol, the < recoveries were up to 95% and ca. 5% on MIP-
3 and NIP-3, respectively (Figure S6). Then, the MISPE procedure was tested with a real 
urine sample, (Figure 6).  
[FIGURE 6] 
Urine, spiked with 5 µg.mL-1 of the 4 standard nucleosides given previously (<, 5, 6 and 7), 
was extracted on both MIP-3 and NIP-3 and analysed with a validated HPLC-UV method 
(Table S10). The recovery for MIP-3 (92±2%) and NIP-3 (2±2%), respectively, shows a very 
clean extract and the possibility for MIP-3 to recognize and capture very selectively < in 
biological fluids. The MISPE method was repeated three times on the same cartridge with the 
RSD < 20% at the recovery step (Table S7). 
 
3. Conclusion 
In conclusion, we have reported for the first time a water-compatible imprinted polymer 
obtained by a stoichiometric approach with a tailor-made functional monomer, for selective 
recognition of pseudouridine urinary tumor marker, with an IF of 70. Indeed, in the 
conception phase, high energy complex between pseudouridine and monomer 3 was 
confirmed both by the 1H-NMR and ITC host-guest studies. Furthermore, in the HPLC 
evaluation as stationary phases, among the four synthesized polymers, those using 
complementary 2,6-diamino pyridine and isopthaloyl derivatives, as monomers 2 and 3,  
exhibited the best behaviour with higher retention times and very good selectivity for the <in 
both organic and aqueous media. The binding affinity isotherms constructed using frontal 
analysis method best fitted to a Bi-Langmuir adsorption model for both MIP-2 and MIP-3, 
with Ka 3. In term of capacity, MIP-3 showed higher total number of binding sites with 
elevated binding capacity compared to the other polymers. In addition, the results of textural 
properties analysed using of MIPs, confirmed a mesoporous structure of the polymers, and 
have shown that significant difference in the surface morphology, was obtained for MIP-3 in 
respect  to its corresponding NIP-3. While the results for textural properties of other prepared 
MIPs are quite similar when compared to their NIPs. These results further demonstrate that 
the stability of complex TAc</3 during polymerization was important in yielding defined and 
easily accessible surface cavities, and can explain better binding capacity of MIP-3 obtained 
in frontal analysis. Therefore, owing to its good properties in both chromatographic and 
morphological properties, MIP-3 was evaluated for the application by the MISPE studies. We 
have successfully developed a MISPE procedure for the use of the synthesised polymer in 
extraction of pseudouridine from aqueous media. Application in synthetic urine was 
compared with that of real urine sample, where high extraction capabilities (95%) of the MIP-
3, specificity (IFrecovery > 40) and selectivity in the cross-rebinding studies were demonstrated. 
This <-MIP, thanks to its very high selectivity, its ease of polymeric synthesis, its use in an 
aqueous medium, opens the route to the development of MIP-based chemosensors[36], based 
on differential pulse voltammetry, capacitive impedimetry or piezoelectrical microgravimetry 
response,[10] as promising new tools for cancer biomarker determination. 
 
4. Experimental Section  
Materials: All solvents and reagents were purchased from Sigma±Aldrich (Saint-
4XHQWLQ)DOODYLHU)UDQFHDQGXVHGDVUHFHLYHG3VHXGRXULGLQHȌZDVREWDLQHGIURP
&DUERV\QWK &RPSWRQ 8. ¶¶¶-tri-O-acetylpseudouridine (TAc<) was prepared from 
pseudouridine and acid anhydride using a literature method (cf. supporting informations).[37] 
The nucleosides (see Figure 4) 5-fluorouracil (5), cytidine (8), guanosine (9), adenosine (10), 
N4-acetylcytidine (11), 8-hydroxy-¶-deoxyguanosine (12), 1-methylinosine (13), 1-
methylguanosine (14), 7-methylguanosine (15) and 1-methyladenosine (16) were purchased 
from Sigma±Aldrich (Saint-Quentin Fallavier, France). Uridine (6) and 5-methyluridine (7) 
were purchased from Alfa Aesar (Schiltigheim, France). All the nucleoside bases, nucleosides 
and their analogues were stored at 4°C and used as received. Azo-bis-dimethylvaleronitrile 
(ABDV) (DuPont, Netherlands) was kept at -20°C. Acrylamide (1) was purchased from 
Sigma-Aldrich (Dorset, UK), and monomers (2), and (3) plus (4) were synthesised following 
the protocol established by K. Yano et al. [38] or as described below, respectively. Ethylene 
glycol dimethacrylate (EGDMA) was purchased from Sigma±Aldrich (Saint-Quentin 
)DOODYLHU)UDQFHDQGSXULILHGE\GLVWLOODWLRQEHIRUHXVH'HLRQLVHGZDWHUaPȍXVHGIRU
the analysis and preparation of solutions was obtained using a water purification system 
(Millipore, Fontenay-sous-Bois, France). Surface area analyses were performed at 77K by 
Brunauer±Emmett±Teller (BET) on an ASAP 2020 surface area and porosity analyser 
(Micromeritics Instrument Corporation, Creil, France). The studies were made using 60 mg of 
each polymer, which was degassed overnight at 100°C to remove adsorbed gases and 
moisture. The 1H-NMR and 13C-NMR spectra were obtained on a JEOL ECA, 400MHz FT 
NMR Spectrometer (Jeol, UK). Chemical shifts are reported in ppm on the į scale relative to 
TMS as internal standard or to the solvent signal used. HRMS spectra were obtained using a 
Waters Synapt G2 TOF mass spectrometer (Waters, Elstree, UK) with an electrospray 
ionization probe in positive mode. HPLC analyses were performed using an Agilent Infinity 
1260 system equipped with a diode array detector and a binary pump (Agilent, Les Ulis, 
France). The HPLC analyses of extraction samples, and validation of the used HPLC analysis 
method, was performed using a PGC Thermo Hypercarb® (ThermoFisher Scientific, 
Courtaboeuf, France) column (150 × 2.1 mm i.d., ȝPZLWK89GHWHFWLRQDWQPIRUDOO
analytes. For frontal analysis stainless steel chromatographic columns (50 mm x 4.6 mm i.d.) 
ZHUHSDFNHGXVLQJWKH66,³SDFNLQDER[´V\VWHP5HVWHN3DULV)UDQFH 
Solubility tests: of the TAc< and monomers (1-4) were performed in a range of 
solvents differing in their isoelectric constants and hydrogen bonding capabilities. The testing 
was carried out separately by raising the mass of the templates or monomer in 1 mL of 
solvent and subsequently mixing until precipitation was observed. The wanted solubility limit 
for the polymers synthesis was 100 mM. The results are presented in Table S1. 
Molecular modelling: all the density functional theory (DFT) computations were 
performed on the Beowulf cluster at the Institute of Pharmacology Polish Academy of 
Sciences (IPPAS) in Cracow (Poland). The B3LYP (Becke-Style 3-Parameter DFT using the 
Lee±Yang± Parr correlation function) with 6-31+G (d,p) basis set was used for geometry 
optimization to obtain minimum energy structures. In order to avoid the basis-set 
superposition error (BSSE) related with intermolecular interactions theory, the counterpoise 
(CP) correction was applied to complex calculations in order to obtain accurate computation 
of molecular interactions Gibbs free energies by DFT methods.[39] Interaction Gibbs free 
HQHUJLHVRIFRPSOH[HVZHUHFDOFXODWHGXVLQJ(T6ZKHUHǻ*LV WKHFKDQJH LQ*LEEVIUHH
energy on the formation of template±monomer complex, Gtemplate±monomer complex is the Gibbs 
free energy of template±monomer complex, Gtemplate is the Gibbs free energy of template and 
Gmonomer is the Gibbs free energy of monomer molecules. All calculations were performed in 
Jaguar [40,41] and shown in Table 1. 
Equation 1ǻ* *WHPSODWHíPRQRPHUFRPSOH[ í>*template + Gmonomer]  
NMR titrations: The complexation induced shift (CIS) of a relevant proton between 
WKH IXQFWLRQDO PRQRPHUV  WR  DQG ¶¶¶-Tri-O-acetylpseudouridine (TAc<) was 
analysed in deuterated chloroform. To a 1 mM monomer solution an increasing volume of 
WHPSODWH  P0 VWRFN VROXWLRQ ZDV DGGHG DV D JXHVW PROHFXOH * 7KH VKLIW ǻį RI WKH
protons in the monomer amido functionalities were followed (NMR titration spectra are 
shown in Figure S1 and Table 1). The ǻįZDVSORWWHGDJDLQVWWKHFRQFHQWUDWLRQRIIUHHJXHVW
and the curve that is produced is fitted to a non-linear binding isotherm, using OriginPro 8.5.1. 
The apparent binding constant (Kapp DQG WKH PD[LPXP LQGXFHG VKLIW ǻHG made by the 
complex are calculated from the equation of the curve with the help of equation S2, based on 
a 1:1 binding model.[42] 
Equation 2:  ߂ߜ ൌ ௄ೌ೛೛Ǥሾீሿଵା௄ೌ೛೛Ǥሾீሿ߂ுீ  
 
ITC titrations: Calorimetric measurements were performed in chloroform on a 
computer-controlled VP-ITC microcalorimeter (Microcal, GE HealthCare, Aulnay-sous-Bois, 
France) against a reference solution of 100% chloroform. Binding curves were obtained from 
nonlinear analysis of the isotherms using Origin 7 (OriginLab Corp.) analysis package 
provided by Microcal, Inc. The software allowed calculating the Kb 1 ǻ+ DQG ǻ6[43] 
Experiments were carried out in anhydrous chloroform, where the 0.2 mM solution  monomer 
(2 mL) was placed in the calorimeter cell, and the titration syringe was loaded with 2 mM of 
the template (at a 10 times higher concentration of the guest to the host). Test (blank) 
titrations were carried out with only solvent in both syringe and the cell to be sure that the 
device is clean and no background causing errors would appear. The titrations were obtained 
at 20°C (293.15 K) with 28 injections of 10 µL each, and time intervals of 180s with a 
UHIHUHQFH SRZHU RI  ȝFDOV±1. All thermodynamic parameters are shown in Table 1 and 
curves of titration in Figure S2. 
Synthesis of polymers: Following the formulations in Table 2, for the synthesis of 
MIPs, the template, monomer and EGDMA in CHCl3 were introduced to a borosilicate 
polymerization tube, cooled on ice and degassed for 5 min with nitrogen bubbling in order to 
remove dissolved oxygen. ABDV (1% mol.mol-1 of cross-linker) was added and the tube was 
then sealed. The polymerization was initiated by placing the tubes in an oil bath set at 45 °C. 
Polymerization was allowed to continue for a period of 24 hours, after which time the tubes 
were removed from the oil bath, broken with a hammer and the monolithic polymers 
removed. The resulting monoliths were lightly crushed to give smaller particles, which were 
extracted with a mixture of MeOH/AcOH (90/10, v/v) using a Soxhlet apparatus (60 mm x 94 
mm) during 20 hours. The polymers were then crushed and sieved to 25-50 µm. These 
particles were subjected to sedimentation in acetone (4 times) to remove fine particles prior to 
further use. The washing extracts were evaporated to dryness and weighed. Non-imprinted 
polymers (NIPs) were prepared in the same manner as imprinted polymers (MIPs) for each 
formulation.  
Imprinting efficiency evaluation by HPLC: Polymer particles (25±50 µm, 310 mg dry 
weight) were slurry packed into stainless steel HPLC columns (50 mm x 4.6 mm i.d.), using 
an SSI Pack-In-A-Box system (Restek, Paris, France) with MeOH/H2O (4/1, v/v) mixture as 
the mobile phase at a continuous flow of 15 mL.min-1 for 4 min (~300 bars). The packed 
columns were then evaluated by HPLC injection method using an Agilent Infinity 1260 
system equipped with a diode array detector and a binary pump (Agilent, Les Ulis, France). 
Acetonitrile with 1% acetic acid (v/v) was used as mobile phase for the organic phase 
behaviour and synthetic urine (Table S2 and S3) for the aqueous phase behaviour and the 
column was equilibrated until a stable baseline was observed. For HPLC retention 
characterisation on the synthesized polymers, 5 mM stock solutions of nucleosides were 
prepared in deionised water, and diluted to 1mM, prior to analysis. HPLC analyses were 
SHUIRUPHGE\LQMHFWLQJȝ/RIP0DQDO\WHVROXWLRQVDW&XVLQJDIORZUDWHRIP/PLQ-
1
. The elution profiles were recorded at 260 nm. All injections were repeated several times 
(n=3), alternating between different analytes. The retention factors (k') of each analyte, were 
calculated as k' =  (tR-t0)/t0, where t0 is the retention time of the void marker (acetone). 
Imprinting factors (IF) were calculated using the formula IF =  k' (MIP)/k' (NIP). All these 
data are presented in Table S2, Table S3, and Figure S3 and Figure S4. 
Measurement of adsorption isotherms by HPLC frontal analysis: Staircase frontal 
chromatography was performed on each imprinted and non-imprinted polymer, with template 
TAc<. The mobile phase used was MeCN/AcOH (95/5, v/v) at 25 °C and at the flow rate of 1 
mL.min-1. A step-wise gradient was applied, mixing 10% increments of prepared template 
solutions in the mobile phase and pure mobile phase. Finally, a staircase frontal 
chromatogram with a total of 30 steps in the TAc< concentration range of 10-6 to 10-3 M was 
obtained. Therefore, the analysis was performed using three separate solutions of the 
corresponding template (10-6-10-5, 10-5-10-4 and 10-4-10-3 M), at the wavelength 260 or 280 
nm depending on the saturation of the detector. The breakthrough volume for a non-retained 
analyte was measured by eluting the columns with MeCN/AcOH (95/5, v/v) containing 1% 
acetone (v/v %) as void marker. The obtained isotherms were fitted to Langmuir, Freundlich, 
Langmuir-Freundlich and Bi-Langmuir model, using the Origin Pro 8.5.1 software. 
Modelling of frontal analysis: The raw data were adjusted to four mathematical 
models which account for the energetic heterogeneity of the polymers (Freundlich (FI), 
Langmuir (LI), Langmuir-Freundlich (L-FI) and Bi-Langmuir (Bi-LI)). The tested models use 
calculations based on isothermal (25 °C) equilibrium adsorption thermodynamics. From each 
concentration step, the corresponding amount of the bound analyte (Q) was calculated and 
plotted against the corresponding template concentration (Cf) in the mobile phase. The raw 
data were then fitted to theoretical isotherms using non-linear regression analysis (Table S7), 
and the affinity constants (Ka) and relative number of binding sites (N), and from some of the 
models the heterogeneity parameter (m), were obtained. The correlation coefficient (R2) is 
one of the parameters frequently used as a measure of fit quality, although when the R2 values 
of the fit are close between models (as obtained for MIP-2 and MIP-3), the Fisher value (F) 
can be used as a measure of choice of the best fit (Figure 5 and Table S5). 
BET measurements: Specific surface area (Sa), pore size (dp) and pore volumes (Vp) as 
well as full nitrogen adsorption and desorption isotherms at 77K were analysed using 
Brunauer±Emmett±Teller (BET) model with ASAP 2020 surface area and porosity analyser 
(Micromeritics Instrument Corporation, Creil, France). Polymers (100mg) were degassed 
overnight at 100ƕC, to remove adsorbed gases and moisture prior analysis (Table S6).  
Solid phase extractions: Imprinted and non-imprinted particles (50 mg) were packed 
LQP/SRO\SURS\OHQH FDUWULGJHVEHWZHHQȝPSRURXVSRO\HWK\OHQH IULWV7KHRSWLPLzed 
MISPE protocol consisted of a cartridge conditioning step with 3 mL of MeOH, followed by 
3 mL of deionized water, prior to loading 1 mL of synthetic urine[8] (Figure S5 and Table S7) 
or  real urine samples containing a mixture of < with its analogues 5, 6 and 7 (named Pseu 
PL[ ZKLFK FRXOG EH ILQG LQ WKH KXPDQ XULQH  ȝJP/-1) (Figure 6). Following an initial 
aqueous WASH 1 (0.5 mL), 1 mL of organic solvent MeCN was used as WASH 2. Retained 
compounds were finally eluted with 3 mL of MeOH/formic acid (90/10, v/v). The extraction 
procedure was performed passing the sample and solutions through the cartridge by gravity, 
slowly pushing the liquid to maintain the 1 mL.min-1 flow rate. For the real urine extraction, 
the morning urine samples were collected from 3 healthy volunteers (male and women) in the 
age between 23-30 years old, mixed together and kept at -20°C till one hour prior to analysis. 
The urine was of a normal smell, light yellow colour and pH 6-7. The collected synthetic and 
real urine extraction fractions were evaporated under a N2 stream and re-solubilised in 0.5 mL 
of mobile phase A, and then analysed by HPLC-DAD (factor of concentration = 2). 
HPLC method validation for pseudouridine detection in spiked urine samples: For the 
analysis of MISPE fractions, a linear gradient method with a mixture of mobile phase A (25 
mM NH4OAc buffer, pH=5.5) and B (MeCN/formic acid, 99.8/0.2, v/v) was developed. The 
gradient consisted of beginning on 10% B going to 15%B for 0-8 min (0.2 mL.min-1), and 
then isocratic at 15%B for 8-30 min (0.3 mL.min-1). The retention times were (time ± SD): 5-
fluorouridine (5) (7 ± 0.08 min), pseudouridine (< (10 ± 0.1 min), uridine (6) (13 ± 0.1 min) 
and 5-methyluridine (7) (28 ± 0.05 min). The results of extraction were taken from the 
chromatographic analysis in a way that, for each nucleoside the peak area obtained after the 
extraction step was divided by the one obtained before extraction (used as reference sample), 
giving finally the extraction % for that step. The calculated ratios were used to quantify the 
extraction performance for all MISPE steps (Table S8). 
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Figure 2. Template and monomers used for the development of polymer for < recognition; <, 






Figure 3. Theoretical presentation according to the 1H-NMR results of template-monomer 
TAc</2 (A and D), TAc</3 (B and E) and TAc</4 (C and F) complexes with the possible 
hydrogen interactions (red dotted line), secondary negative interactions between the hydrogen 
bond donor groups (blue dotted line), and secondary negative interactions between the 





Figure 4. Urinary nucleosides and close pseudouridine (<) analogues used for the HPLC 









Figure 5. Experimental data obtained by frontal staircase method analysis for each MIP/NIP 
with the template analogue TAc< (MIP-1: cross, MIP-2: filled circles, MIP-3: filled 
diamonds and MIP-4: filled squares, NIP-1: cross, NIP-2: empty circles, NIP-3: empty 
diamonds and NIP-4: empty squares). Inserted figure: data from the low concentration area, 











Figure 6. Chromatograms obtained during urine sample cleanup with MIP-3. HPLC analysis 
conditions: Hypercarb® (150x2.1 mm, 5µm) column, Mobile phase (A): NH4OAc buffer (25 
mM) pH 5.5, Mobile phase (B): MeCN/FA (99.8/0.2, v/v), gradient elution method used 
going from 10% B going to 15%B for 0-8 min (0.2 mL.min-1), and then isocratic at 15%B  for 
8-30 min (0.3 mL.min-1). Peak assignment: 5 (5-fluorouracil), < (pseudouridine), 6 (uridine) 
and 7 (5-methyluridine). A: reference solution of Pseu mix (5 µg.mL-1) in synthetic urine, B: 
non-spiked healthy urine, C: spiked healthy urine with Pseu mix (final concentration 5 µg.mL-





Table 1. Results of 1H-NMR titration, ITC and DFT calculations to 1:1 binding model for 
pre-polymerization complexes; all data were calculated in chloroform, but also in mixture of 




NMR titration  ITC measurement  DFT 
Kapp  (M-1) ǻHG (ppm)  N Kb (M-1) ǻ+ ǻ6 ǻ*  ǻ*corr (water) 
ǻ*corr 
(CHCl3) 
TAc</2 211 ± 3.62 2.27 ± 0.02  1.34 ± 0.02 1500±48 -2.9± 0.046 4.5 -4.2  -44.211 -49.027 
TAc</3 352 ± 49 0.80 ± 0.04  1 ± 0.02 379000±1450 -11.5± 0.059 -15 5.6  -51.255 -51.255 
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6\QWKHVLVRI¶¶¶-tri-O-acetylpseudouridine (template, TAc<): 
The synthesis was a modified version of previously reported procedure by Winqvist et al.[37] 
In short, pseudouridine (732 mg, 3 mmol) was stirred in dry pyridine (6 mL) and acetic 
anhydride (0.983 mL, 1.061 g, 10.5 mmol) at 20 °C under N2 atmosphere for 25 hours. After 
this time, the reaction mixture was concentrated and the residue dissolved in dichloromethane 
(75 mL). The organic solution was washed with saturated aqueous NaHCO3 (50 mL). The 
aqueous phase was then extracted with dichloromethane (4 x 50 mL) and the combined 
organic phases dried over MgSO4. After filtration, the solvent was removed under vacuum to 
obtain a white solid, which was purified by chromatographic column (silica gel, 3% methanol 
in DCM). The TAc< template was obtained as a white solid and dried overnight under 
vacuum at 50°C to eliminate traces of pyridine and acetic acid. Finally, 930 mg of TAc< was 
obtained in 84% yield. 1H-NMR (400 MHz, CDCl3įDQGV+&2&+3), 
4.25-4.30 (m, 3J +]++¶-4.40 (m, 3J=+]++¶G3J=4.4 Hz, 
++¶W3J=+]++¶W3J +]++¶V++
(s, 2H, NH). 13C-NMR (100 MHz, CDCl3 į   DQG  &2&+3), 63.6 (C-¶
71.2 (C-¶  &-¶  &-¶  &-¶   &-6), 152.4, 162.8, 169.8, 
169.9, 171.1. IR: 1131.7, 1227.0, 1508.4, 1579.1, 1675.2, 1723.2, 2962.6, 3225.7 cm-1. 
HRMS (ESI) m/z: [M+H]+ calcd for C15H19N2O9, 371.109; found, 371.108. 
 
Synthesis of 2,6-bis(acrylamido)pyridine (monomer 2): 
The synthesis was based on previously reported procedure by K. Yano et al.[38] To a solution 
of 2,6-diaminopyridine (8, 2 g, 0.018 mol), triethylamine (0.055 mol, 7.66 mL) and anhydrous 
dichloromethane (150 mL), 3.72 mL of acryloyl chloride (0.0458 mol) dissolved in 15 mL of 
dichloromethane was added slowly in an ice bath and under a dinitrogen atmosphere. The 




quench any unreacted acryloyl chloride. The organic layer was then extracted with saturated 
aqueous sodium bicarbonate (2 x 100 mL) and brine (100 mL). The organic layer was 
collected and dried over MgSO4, filtered and distilled. The residue was then purified by 
column chromatography (6:4, petroleum ether-ethyl acetate). The monomer was precipitated 
into petrol ether from dichloromethane to obtain monomer 2 as white crystals (1.73g, 45%). 
1H NMR (100 MHz, DMSO-d6į5.79 (dd, 2J=2 Hz, 3J=10.2  Hz, 2H, -CHcis =), 6.31 (dd, 
2J=2 Hz, 3J=17 Hz, 2H, -CHtrans=), 6.65 (dd, 3Jcis=10  Hz, 3Jtrans=17.2 Hz , 2H, CH= ), 7.79 
(dd, 3J=6.8, 2.4 Hz, 1H, CH-Ar), 7.87 (d, 3J=7.2  Hz, 2H, CH-Ar), 10.31 (s, 2H, NH) ppm. 
13C NMR (100 MHz, CDCl3 į  &+-Ar), 128.8 (CH2=), 130.8 (CH=), 141.0 (C-H), 
149.5 (C=O), 163.5 (C=N) ppm. IR: 694.7, 979, 1313, 1584, 1677, 3325 cm-1. M.p. = 115-
118°C. HRMS (ESI-TOF) m/z: [M+H]+ calcd for C11H11N3O2H, 218.22; found, 218.0934. 
 
Synthesis of 1,3-bis[[5-vinylpyrid-2-yl)amido]carbonyl]5-tert-butyl-benzene (monomer 
3): 
 
(i) 5-Tert-butyl isophthalic acid (27.9 mmol, 6.2 g) and 2-amino-5-bromopyridine (63 mmol, 
10.73 g) were dissolved in 16.7 mL of dimethylformamide. Pyridine (15.74 mL, 82mmol) 
was added and the mixture left to react for 30 minutes. Then, T3P (50 wt% in DMF, 94.32 
mmol, 60 mL) was added dropwise at -20 oC (ice-NaCl bath) after which the reaction was left 
to stir overnight at room temperature. The next day the solvent was removed and the crude 
product precipitated in water and filtered. The brown solid was sonicated for 30 minutes in 
100mL 1 N aqueous NaOH (twice) and filtered. The white solid was dried overnight to obtain 




CH3), 8.11 (dd, 2J=2.4 Hz, 3J=9.2  Hz, 2H, -CH4), 8.20 (d,  3J=1.6 Hz, 2H, -CH3), 8.24 (d, 
3J=8.8  Hz, 2H, -CH6), 8.44 (t, 3J=1.6  Hz, 1H, Ph-CH-2),  8.55 (dd, 2J= 0.8 Hz,  3J=2.4 Hz, 
2H, Ph-CH-4 and 6), 11.10 (s, 2H, NH). 13C NMR (100 MHz, DMSO-d6): į 31.4 (tert-butyl-
CH3), 35.4 (tert-butyl-C), 114.6 (Py-CH2[C-5]), 116.6 and 141.3 (Py-CH2[C-3] & Py-CH2[C-
4]), 125.7 (Ph-C-2), 129.0 (Ph-C-4), 134.2, 149.1 (Py-CH2[C-6]),  151.7, 152.1, 166.2. 
HRMS (ESI-TOF) m/z:  [M-H+]  calcd for C22H20Br2N4O2, 532.23; found, 531.0032. IR: 740, 
881. 1091, 1213, 1369, 1499, 1566, 1683, 2962, 3423 cm-1. M.p. = 227-228°C 
 
 (ii) A stirred solution of intermediate 1 (2.9 g, 5.45 mmol) in DME under dinitrogen 
atmosphere was treated with palladium(0)tetrakis-triphenylphosphine (0.552 mmol, 0.638 g). 
The reaction mixture was stirred at room temperature for 20 minutes and 2,4,6-
trivinylcyclotriboroxane (5.64 mmol, 1.36 g), K2CO3 (11.28 mmol, 1.56 g) and water were 
added. The reaction mixture was heated under reflux (108 °C) for 2 hours. The reaction 
mixture was concentrated and the crude product precipitated from water. The crude product 
was purified by column chromatography (dry column: alumina, PE:EtOAc 7:3) to obtain 
monomer 3 (1.13 g, 49%). 1H NMR (400 MHz, DMSO-d6įV+ tert-butyl-CH3),  
5.34 (dd, 2J=2 Hz, 3J=11.2Hz, 2H, CHcis =), 5.93 (dd, 3J=18 Hz, 2H, CHtrans=), 6.77 (dd, 
3Jcis=11.2 Hz, 3Jtrans= 17.6 Hz, 2H, -CH=), 8.06 (dd, 2J=2.4 Hz, 3J=8.8  Hz, 2H, -CH4), 8.20 (d,  
3J=1.2 Hz, 2H, -CH3), 8.28 (d, 3J=8.8  Hz, 2H, -CH6), 8.46 (s, 1H, Ph-CH-2),  8.49 (d, 3J=2.4 
Hz, 2H, Ph-CH-4 and 6), 10.99 (s, 2H, NH). 13C NMR (100 MHz, DMSO-d6): į 31.4 (tert-
butyl-CH3), 35.4 (tert-butyl-C), 114.6 (-CH=),  115.6 (CH2=), 125.5 (Ph-C-2), 128.9 (Ph-C-4 
and 6), 129.6, 133.5 (Py-CH2[C-4]), 134.4 (Py-CH2[C-3]), 146.9 (Py-CH2[C-6]), 135.4, 152.0, 
152.2, 166.1. HRMS (ESI-TOF) m/z: [M+H]+ calcd for C26H26N4O2H, 427.51; found, 





Synthesis of 1,3-bis[[6-bisacrylamid-2-yl)amido]carbonyl]5-tert-butyl-benzene 
(monomer 4) 
 (i) 
(i) 1,3-bis[[6-amino-2-yl)amido]carbonyl]5-tert-butyl-benzene (intermediate 2). 5-tert-
butilisophthalic acid (3 g, 0.0135 mol, 1eq) was refluxed with 20 mL of SOCl2 for 4 h. The 
solvent was then evaporated to obtain the corresponding diacid chloride, which was dissolved 
in 20 mL of dry THF and added dropwise to a solution of 2,6-diaminopyridine (14.73 g, 0.135 
mol, 10 eq) and triethylamine (TEA) (3.76 mL, 2.73 g, 0.027 mol, d=0.726) in anhydrous 
THF (220 mL) at 0°C and under dinitrogen atmosphere. The reaction mixture was stirred at 
room temperature overnight. The next day the solvent was evaporated and the crude product 
washed with water. The sticky solid was filtered, dissolved in hot ethyl acetate and filtered 
again. The filtrate was evaporated to obtain a brown solid, which was then purified with a 
chromatographic column using silica gel as the stationary phase and ethyl acetate as the eluent. 
The first fraction coming out of the column was the desired intermediate (light brown solid, 
88%). 1H NMR (400 MHz, DMSO-d6): į 1.37 (s, 9H, tert-butyl-CH3 ),  5.79 (s, 4H, NH2), 
6.29 (dd, 2J=0.8  Hz, 3J=8  Hz, 2H, Py-CH2[H-5]), 7.41 (dd,  2J=0.8 Hz, 3J=8  Hz, 2H, Py-
CH2[H-3] ), 7.45 (t, 3J=7.6  Hz, 2H, Py-CH2[H-4]), 8.11 (d, 3J=1.2  Hz, 2H, Ph-CH-4 and 6), 
8.33 (s, 1H, Ph-CH-2), 10.292 (s, 2H, NH). 13C NMR (100 MHz, DMSO-d6): į 31.5 (tert-
butyl-CH3), 35.3 (tert-butyl-C), 102.4 (Py-CH2[C-5]), 104.6 and 139.5 (Py-CH2[C-3 and C-
4]), 124.8 (Ph-C-2), 128.5 (Ph-C-4 and 6), 134.6, 150.9, 151.9, 159.1, and 165.7. HRMS 
(ESI-TOF) m/z: [M+H]+ calcd for C22H25N6O2H, 405.46; found, 405.203. IR: 1526.6, 1614.9, 




(ii) 1,3-bis[[6-bisacrylamid-2-yl)amido]carbonyl]5-tert-butyl-benzene (monomer 4). To a 
solution of intermediate 2 (3.5g, 8.65 mmol, 1 eq) and triethylamine (3.61 mL, 2.62 g, 25.95 
mmol, d=0.726, 3 eq) in anhydrous THF (180  mL), 1.75 mL of acryloyl chloride (1.95 g, 
21.62 mmol, FW=90.51, d=1.114, 2.5  eq) in 20 mL of THF was added slowly at 0°C and 
under dinitrogen atmosphere. The reaction mixture was stirred at room temperature overnight. 
The next day the precipitate was filtered off and the solvent evaporated. The residue was 
washed with water and a saturated solution of sodium bicarbonate (NaHCO3). The solid was 
then sonicated in 100 mL of DCM. Monomer 1 was obtained as a white solid in a 52% yield 
(2.3g). 1H NMR (400 MHz, DMSO-d6): į 1.41 (s, 9H, tert-butyl-CH3),  5.80 (dd, 2J=2 Hz, 
3J=12 Hz, 2H, CHcis =), 6.33 (dd, 2J=1.6 Hz, 3J=20 Hz, 2H, CHtrans=), 6.67 (dd, 3Jcis=10.4 Hz, 
3Jtrans=16. Hz, 2H, -CH= ), 7.87 (m,  3J=8  Hz, 4H, Py-CH2[H-3 and H-4]), 7.95 (m,  3J=4  Hz, 
2H, Py-CH2[H-5]), 8.21 (d, 3J=1.6  Hz, 2H, Ph-CH-4 and 6), 8.382 (s, 1H, Ph-CH-2), 10.45 (s, 
2H, NH-C6), 10.59 (s, 2H, NH-C2). 13C NMR (100 MHz, DMSO-d6): į 31.5 (tert-butyl-CH3), 
35.5 (tert-butyl-C), 110.7 (Py-CH2[C-5]), 111.5 and 140.7 (Py-CH2[C-3 and C-4]), 125.7 (Ph-
C-2), 128.4 (CH2=), 128.6 (Ph-C-4 and 6), 132.1 (-CH=), 134.6, 150.9, 151.0, 152.0, 164.3 
and 166.1. HRMS (ESI-TOF) m/z: [M+H]+ calcd for C28H29N6O4H, 513.56; found, 513.224. 













Table S1. The solubility results of TAc< and monomers (1-4). 








Chloroform 25 3.1 5.7 4.81 
100  (1) 
100  (2) 
100 (3) 
 100  (4) 
100  
  






Acetonitrile 25 18 6.1 37.5 
Dimethyl sulfoxide   
 







25 16.4 10.2 46.68 
1,4-dioxane/THF 







Hansen solubility parameters (MPa1/2):  a polarity     b hydrogen bonding ability ; N.D. : not determined 
 







Figure S1.B: 1H-NMR titration of monomer 3 ZLWK¶¶¶-Tri-O-acetylpseudouridine 
 




















Table S2. HPLC polymer retention analysis of MIP-1, MIP-2, MIP-3 and MIP-4, and corresponding NIPs, in organic mobile phase 
 
a Į<) = kt(<)/ kx;  pseudouridine (<) , x = structurally related analyte 
k = (tR-t0)/t0;  t0 = retention time of acetone (0.75±-0.01) , tR =  retention time of analyte, 
b IF = k (MIP)/k (NIP).    
C
 SD (standard deviation of analysis, n=3) 
* Elution time > 40 min,     N/D ( non-determinate) 
d
 RSD % =(SD/mean)* 100 
MeCN /AcOH (99 /1, v/v) 
Polymer Parameter TAc< < 6 7 8 9 10 11 12 13 14 15 16 RSD d % 
MIP±1 
k ± SDc 
 
4.25±0.05 1.52±0.2 1.32±0.05 2.47±0.04 4.82±0.3 3.11±0.2 1.71±0.04 9.29±0.74 4.93±0.05 1.02±0.02 3.43±0.03 2.17±0.04 < 10 
Į<)  0.23 1.00 2.79 3.22 1.72 0.88 1.37 2.48 0.46 0.86 4.17 1.24 1.96 
 
IF 18.45 1.62 1.13 1.20 0.86 1.03 1.81 1.35 1.21 7.25 0.94 1.27 2.24 
 
MIP±2 
k ± SD >40* >40* 32.78±0.5 16.99±0.8 8.45±0.7 2.17±0.04 1.3±0.03 1.23±0.06 11.69±0.8 6.02±0.05 1±0.08 2.49±0.12 1.62±0.06 < 5 
Į<) N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
 
IF >91 >29 20.11 10.11 4.97 4.43 1.57 0.89 1.94 13.09 2.22 1.98 3.24 
 
MIP±3 
k ± SD >40* >40* >40* 13.91±0.7 9.31±0.07 7.55±0.25 5.07±0.03 5.62±0.06 10.05±0.2 4.95±0.25 1.7±0.3 6.19±0.04 4.58±0.01 < 5 
Į<) N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
 
IF >65 >25 >2 1.06 5.48 5.07 4.49 9.06 1.05 8.25 2.46 5.20 6.03 
 
MIP±4 
k ± SD 21.09±0.08 19.79±0.3 16.05±0.5 13.12±0.4 4.18±0.2 5.14±0.8 6.83±0.5 5.71±0.3 10.61±0.3 3.53±0.4 1.2±0.05 2.36±0.06 2.14±0.04 < 5 
Į<) 0.94 1.00 1.23 1.51 4.73 3.85 2.90 3.46 1.87 5.61 16.49 8.39 9.25 
 
IF 19.53 2.92 3.77 3.12 3.34 2.04 3.25 4.57 1.23 12.17 2.67 2.59 1.26 
 
NIP±1 k ± SD 0.99±0.05 2.62±0.03 1.35±0.04 1.1±0.02 2.88±0.07 4.68±0.08 1.72±0.5 1.27±0.4 7.7±0.52 0.68±0.04 1.09±0.06 2.7±0.8 0.97±0.09 < 6 Į<) 2.65 1.00 1.94 2.38 0.91 0.56 1.52 2.06 0.34 3.85 2.40 0.97 2.70 
 
NIP±2 k ± SD 0.44±0.2 1.36±0.05 1.63±0.25 1.68±0.5 1.7±07 0.49±0.8 0.83±0.6 1.38±0.04 6.03±0.06 0.46±0.5 0.45±0.5 1.26±0.9 0.5±0.04 < 6 Į<) 3.09 1.00 0.83 0.81 0.80 2.77 1.64 0.99 0.23 2.96 3.02 1.08 2.72 
 
NIP±3 k ± SD 0.62±0.08 1.62±0.09 17.32±0.5 13.18±0.4 1.7±0.2 1.49±0.06 1.13±0.4 0.62±0.8 9.58±0.07 0.6±0.09 0.69±0.04 1.19±0.6 0.76±0.03 < 6 Į<) 2.61 1.00 0.09 0.12 0.95 1.09 1.43 2.61 0.17 2.70 2.35 1.36 2.13 
 






Table S3. HPLC polymer retention analysis of MIP-1, MIP-2, MIP-3 and MIP-4, and corresponding NIPs, in aqueous mobile phase 
a Į<) = kt/ kx;  pseudouridine (<) , x = structurally related analyte 
 k = (tR-t0)/t0;  t0 = retention time of acetone (0.95±-0.01) , tR =  retention time of analyte, 
b IF = k (MIP)/k (NIP).    
C
 SD (standard deviation of analysis, n=3) 
* Elution time > 40 min,     N/D ( non-determinate) 
Synthetic urine 
Polymer Parameter TAc< < 6 7 8 9 10 11 12 13 14 15 16 RSD d % 
MIP±1 
k ± SDc 0.6±0.05 0.11±0.6 0.15±0.09 1.67±0.8 0.22±0.06 2.09±0.06 5.83±0.07 2.94±0.06 6.17±0.02 1.78±0.06 3.67±0.09 3.81±0.02 13.22±0.4 < 8 
Į<)  0.18 1.00 0.73 0.07 0.50 0.05 0.02 0.04 0.02 0.06 0.03 0.03 0.01 
 
IF 1.87 0.42 0.20 0.95 0.81 0.96 0.86 0.93 0.91 1.01 1.00 1.44 1.13 
 
MIP±2 
k ± SD 36.2±0.06 2.65±0.5 1.94±0.1 3.07±0.2 0.1±0.05 1.22±0.03 7.33±0.2 3.79±0.05 7.46±0.09 2.5±0.3 4.49±0.5 0.21±0.06 1.18±0.2 < 6 
Į<) 0.07 1.00 1.37 0.86 26.50 2.17 0.36 0.70 0.36 1.06 0.59 12.62 2.25 
 
IF 2.36 44.17 3.18 1.00 0.50 0.74 1.09 1.20 1.18 1.64 0.82 0.48 0.14 
 
MIP±3 
k ± SD 36.3±0.08 17±0.06 2.7±0.03 3.39±0.4 0.42±0.03 2.75±0.06 10.96±0.1 5.52±0.07 13.6±0.06 2.19±0.04 7.99±0.6 0.47±0.03 12.1±0.06 < 5 
Į<) 0.47 1.00 6.30 5.01 40.48 6.18 1.55 3.08 1.25 7.76 2.13 36.17 1.40 
 
IF 8.58 70.83 3.80 1.57 4.20 1.42 1.51 1.53 1.98 1.53 1.27 4.27 1.26 
 
MIP±4 
k ± SD 6.35±0.03 0.94±0.06 1.85±0.5 4.29±0.1 0.51±0.3 5.04±0.4 4.35±0.02 6.82±0.3 14.9±0.4 3.88±0.6 6.88±0.2 1±0.06 24.2±0.2 < 10 
Į<) 0.15 1.00 0.51 0.22 1.84 0.19 0.22 0.14 0.06 0.24 0.14 0.94 0.04 
 
IF 1.41 3.03 2.08 1.87 1.24 1.77 0.49 1.78 1.70 1.87 1.90 3.45 1.27 
 
NIP±1 k ± SD 0.32±0.02 0.26±0.09 0.75±0.5 1.75±0.08 0.27±0.04 2.18±0.06 6.8±0.1 3.17±0.5 6.81±0.5 1.76±0.08 3.66±0.04 2.65±0.03 11.71±0.3 < 6 Į<) 0.81 1.00 0.35 0.15 0.96 0.12 0.04 0.08 0.04 0.15 0.07 0.10 0.02 
 
NIP±2 k ± SD 15.36±0.5 0.06±0.04 0.61±0.02 3.08±0.3 0.2±0.05 1.64±0.6 6.73±0.02 3.16±0.08 6.32±0.05 1.52±0.2 5.5±0.7 0.44±0.03 8.36±0.9 < 8 Į<) 0.00 1.00 0.10 0.02 0.30 0.04 0.01 0.02 0.01 0.04 0.01 0.14 0.01 
 
NIP±3 k ± SD 4.23±0.03 0.24±0.06 0.71±0.3 2.16±0.8 0.1±0.02 1.94±0.4 7.24±0.04 3.6±0.09 6.88±0.4 1.43±0.06 6.31±0.02 0.11±0.03 9.58±0.04 < 6 Į<) 0.06 1.00 0.34 0.11 2.40 0.12 0.03 0.07 0.03 0.17 0.04 2.18 0.02 
 





Figure S3.  Retention factors (k) and imprinting factor (IF) for target < and its analogues injected in organic mobile phase on MIP-1, MIP-2, MIP-3 
and MIP-4 (A and C) and on  NIP -1, NIP-2, NIP-3 and NIP-4 (B) polymer packed columns. HPLC conditions: MeCN-AcOH (99/1, v/v) as mobile 






































































































Figure S4.  Figure 3. Retention factors (k) and imprinting factor (IF) for target < and its analogues injected in synthetic urine as mobile phase on 
MIP -1 to  MIP-4 (A) and on NIP-1 to NIP-4 (B) polymer packed columns. IF value are presented on graph C. HPLC conditions: synthetic urine as 








































































Table S4. Composition of synthetic urine used.[1] 
Compound Mass (g)a Final concentration (mM) 
Urea 2.425 200 
Uric acid 0.034 1 
Creatinine 0.085 4 
Na3C6H5O7 0.299 5 
NaCl 0.632 54 
KCl 0.451 30 
NH4Cl 0.162 15 
CaCl2 0.09 3 
MgSO4 0.1 2 
NaHCO3 0.04 2 
Na2C2O4 0.007 0.1 
Na2SO4 0.256 9 
NaH2PO4 0.1 3.6 





Table S5.  Frontal chromatography results for MIPs and NIPs (1, 2, 3 and 4); affinity constants (Ka, L.mol-1), number of binding sites (N, µmol.g-1), 




MIP-1 MIP-2 MIP-3 MIP-4 
Ka N m R2 F test Ka N m R2 F test Ka N m R2 F test Ka N m R2 F test 





- 0.9999 75010 
9.5x103 3.78 
- 0.9997 422000 N.D.c 
0.49x103 3.8 0.63x103 43.63 
Freundlicha 0.46x103 0.93 0.67 0.9996 61080 53x103 1.54 0.56 0.9996 45080 16x103 10.05 0.63 0.9985 16750 9.4x103 1.42 0.73 0.9965 6600 
Langmuir- 
Freundlichb 




NIP-1 NIP-2 NIP-3 NIP-4 
Ka N m R2 F test Ka N m R2 F test Ka N m R2 F test Ka N m R2 F test 
Langmuir 1.9x103 0.12 - 0.995 7800 N.D.c N.D.c 0.2x103 3.57 - 0.997 6800 
Bi-
Langmuir 
N.D.c N.D.c N.D.c N.D.c 
Freundlicha 29x103 0.04 0.62 0.996 5200 3x103 1.06 0.95 0.9998 151000 0.4x103 1.06 0.95 0.9998 18000 1x103 0.58 0.92 0.9955 4700 
Langmuir- 
Freundlichb 
0.49x103 0.23 0.76 0.998 9600 0.1x103 4.99 1.12 0.9999 290000 N.D.c 0.86x103 0.2 1 0.9981 7300 
a Average Ka and N values calculated from Rushton et al.[2] 
b Average Ka calculated using Ka= a1/m  






Table S6. Specific surface areas (Sa), mean pore diameters (dp) and pore volume (Vp) 
measured by BET for MIP- and NIP- 1, 2, 3 and 4 
Polymer BET Sa [m².g-1] dP [Å] VP [cm³.g-1] 
MIP-1 218 71 0.25 
NIP-1 210 72 0.22 
MIP-2 146 68 0.10 
NIP-2 141 118 0.07 
MIP-3 296 72 0.302 
NIP-3 9 350 0.003 
MIP-4 204 67 0.25 
NIP-4 196 63 0.19 
Sa- Surface area, dP- Pore diameter, VP- Pore volume 
 
Figure S5. Recoveries of uridine (6), 5-methyluridine (7), 5-fluorouracil (5) and 
pseudouridine (<) from synthetic urine after each step of the optimized MISPE protocol, on 











Table S7. Nucleoside recoveries (%) from real urine samples (n=3) on MIP-3/NIP-3 with 




 MIP-3  NIP-3 
5 41 ± 8 2 ± 1 19 
< 92 ± 2 2 ± 2 7 
6 2 ± 2 1 ± 0.5 13 
7 5 ± 1 1 ± 1 16 
a 6WDQGDUGGHYLDWLRQ6' Ȉ - )2/n-1  














5  < 6 7 
Linear regression                 
R² 0.9997 0.9999 0.9991 0.9999 
Slope 44.31 48.95 55.65 34.23 
y-intercept -48.52 5.94 18.63 35.16 
&DOFXODWHGGHWHFWRUUHVSRQVHWHVWVĮ  
Cochran (Cth (6;2) = 0.62) 0.59 0.55 0.56 0.56 
Fisher (F1th(1;16) = 4.49) 78.3x 103 164.2x 103 18.2x 103 169.3x 103 
Fisher (F2th(4;12) = 5.91) 0.62 1.76 0.08 2.44 
Repeatabilities (ANOVA test)             
LOQ (µg.mL-1) 3.81 4.26 4.64 4.8 
LOD (µg.mL-1) 1.27 1.77 1.39 1.63 
a tR (min) 7.68 10.08 14.5 28.14 
b F 0.41 0.49 3.08 1.91 
P-value 0.62 0.67 0.09 0.2 
a retention time mean value ,     b Fcrit= 4.26  
 
 
[1] S. Chutipongtanate, V. Thongboonkerd, Anal. Biochem. 2010, 402, 110. 
[2] G.T. Rushton, C.L. Karns, K. D. Shimizu., Anal. Chim. Acta 2005, 528, 107. 
[3] Z. B. Alfassi, Z. Boger, Y. Ronen, in Statistical Treatment of Analytical Data, 
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